Fig. 6
From: SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer
SLC2A3 played tumor-promotive roles in vivo. a Sacrificed nude mice treated with SLC2A3-AAV knockdown (AAV-SLC2A3-KD) or control vectors (Control-AAV) and corresponding tumor growth curves. Tumor sizes were measured in triplicate. b Representative subcutaneous tumor IHC analysis for SLC2A3, p-STAT3, and CD163 (representative images are shown). c The proposed role of SLC2A3 in GC progression. Statistical results are shown as mean ± SD, *ρ < .05, **ρ < .001, based on two-way ANOVA or Student’s t-test